PLx Pharma Inc. Common Stock
PLXP
PLXP was delisted on the 12th of April, 2023.
33 hedge funds and large institutions have $25.5M invested in PLx Pharma Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 4 closing their positions.
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
0% more funds holding
Funds holding: 33 → 33 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 11
3.53% less ownership
Funds ownership: 28.29% → 24.76% (-3.5%)
37% less capital inflows, than outflows
Capital inflows: $4.54M | Capital outflows: $7.21M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lombard Odier Asset Management (USA)
New York
|
+$1.65M |
| 2 |
Great Point Partners
Greenwich,
Connecticut
|
+$952K |
| 3 |
Raymond James & Associates
St Petersburg,
Florida
|
+$341K |
| 4 |
Timpani Capital Management
Milwaukee,
Wisconsin
|
+$217K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$137K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Broadfin Capital
New York
|
-$4.56M |
| 2 |
Tourbillon Capital Partners
New York
|
-$1.35M |
| 3 |
Lone Star Value Management
Old Greenwich,
Connecticut
|
-$392K |
| 4 |
Goldman Sachs
New York
|
-$362K |
| 5 |
Ardsley Advisory Partners
Stamford,
Connecticut
|
-$135K |
PLXP Hedge Fund Activity: Q2 2016 in Review
33 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in PLx Pharma Inc. Common Stock (PLXP) for Q2 2016, worth a combined $25.5M — down 8.4% from $27.8M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new PLXP positions and 4 closed out — a net gain of 1 holder — while 11 added to existing stakes and 11 trimmed.
The largest buyer was Lombard Odier Asset Management (USA), opening a new position worth an estimated $1.65M. The largest seller was Broadfin Capital, cutting an estimated $4.56M.
- 33 institutional investors held PLx Pharma Inc. Common Stock (PLXP) as of Q2 2016, unchanged from Q1 2016.
- Funds reported $25.5M of PLx Pharma Inc. Common Stock stock for Q2 2016, down 8.4% quarter-over-quarter.
- 5 funds opened new PLx Pharma Inc. Common Stock positions in Q2 2016 and 4 closed out, a net change of +1 holder.
- The largest PLx Pharma Inc. Common Stock buyer in Q2 2016 was Lombard Odier Asset Management (USA), an estimated $1.65M added.
- The largest PLx Pharma Inc. Common Stock seller in Q2 2016 was Broadfin Capital, an estimated $4.56M sold.
Based on aggregated 13F filings for Q2 2016.